ClinicalTrials.Veeva

Menu

C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance

Yale University logo

Yale University

Status

Completed

Conditions

Glucose Intolerance

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.

Enrollment

46 patients

Sex

Female

Ages

40 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy postmenopausal women
  • ages 40-65

Exclusion criteria

  • smokers
  • diabetes requiring medication

Trial design

46 participants in 2 patient groups

1
Description:
postmenopausal women with glucose intolerance (either pre-diabetes or diet-controlled diabetes)
2
Description:
postmenopausal women with normal glucose tolerance

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems